Metraipolis › archive › dc_c4d7ff2a55d9
Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer — Europe PMC PMID:42140958
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42140958
- DOI
- 10.1038/s41523-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T06:51:06.922Z
- SHA-256 of the archived text
8eb03583a9e46faba88d9480c391d9f20b9fd89f81b8621be931b33a820bb274- Stable URL of this page
https://metraipolis.com/documento/dc_c4d7ff2a55d9
How to cite
Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer — Europe PMC PMID:42140958 — Europe PMC (en), https://europepmc.org/article/MED/42140958 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4d7ff2a55d9 (Metraipolis archive dc_c4d7ff2a55d9, sha256 8eb03583a9e46faba88d9480c391d9f20b9fd89f81b8621be931b33a820bb274)
BibTeX
@misc{dcc4d7ff2a55d9,
title = {Identification and functional validation of EPS15L1 as a key driver of triple-negative breast cancer — Europe PMC PMID:42140958},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42140958},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4d7ff2a55d9; sha256 8eb03583a9e46faba88d9480c391d9f20b9fd89f81b8621be931b33a820bb274},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42140958. Agents can read the archived copy with the MCP tool read_document.